期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 63, 期 -, 页码 58-65出版社
ELSEVIER
DOI: 10.1016/j.intimp.2018.07.023
关键词
Adenosine; gastric cancer; A2aR signaling; immunotherapy
资金
- Top six talents project of Jiangsu Province [2014-wsw-032]
- Natural Science Foundation of Jiangsu Province [BK201508]
Adenosine (ADO), generated by the ectonucleotidase CD39 and CD73 from ATP, interacts with its specific G protein-coupled receptors, which can impair anti-tumor immune responses inhibiting the infiltration and function of CD8(+) T cell and natural killer cell. Recent studies have also identified that ADO pathway plays a critical role in tumor immune surveillance, especially for some non-solid cancers. In addition, although immune checkpoint therapy targeting ADO pathway in gastric cancer is still in an early phase, encouraging results have come out from some drugs targeting ADO pathway. Therefore, target ADO signaling may be a new promising strategy to treat gastric cancer. In this review, we summarized recent works on the role of ADO in cancer immunotherapy and also discussed relative mechanisms underlying the function of ADO signaling in cancer immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据